Casein hydrolysate diet controls intestinal T cell activation, free radical production and microbial colonisation in NOD mice

Diabetologia

Volumn 56, Issue 8, 2013, Pages 1781-1791

  Emani, R ^a   Asghar, M N ^b   Toivonen, R ^a   Lauren, L ^a   Soderstrom M ^c   Toivola, D M ^b   Van Tol, E A F ^d   Hanninen A ^a  

^a Department of Medical Microbiology and Immunology ^*  (Finland)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d Mead Johnson Nutritionals   (United States)

Author keywords

Casein hydrolysate; Dietary intervention; Guanine and cytosine profiling; Gut immune system; In vivo imaging system; Laser capture microscopy; Microbiota analysis; Nonobese diabetic (NOD) mouse; Reactive oxygen and nitrogen species; Type 1 diabetes

Indexed keywords

BUTYRIC ACID; CASEIN HYDROLYSATE; CYTOKINE; FREE RADICAL; LACTIC ACID; LECTIN; PROTEIN REG3G; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SHORT CHAIN FATTY ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEROIDETES; BIOSYNTHESIS; CONTROLLED STUDY; ENTERITIS; EPITHELIUM CELL; EX VIVO STUDY; FATTY ACID SYNTHESIS; FIRMICUTES; ILEUM; IMPAIRED GLUCOSE TOLERANCE; IN VIVO STUDY; INTESTINE CELL; INTESTINE FLORA; MICROBIAL COLONIZATION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTAKE; SMALL INTESTINE; T LYMPHOCYTE ACTIVATION;

ANIMALS; CASEINS; DIET; FEMALE; FLOW CYTOMETRY; FREE RADICALS; INTESTINES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 84879957089     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-2941-x     Document Type: Article

References (43)

1. Lefebvre DE, Powell KL, Strom A, Scott FW (2006) Dietary proteins as environmental modifiers of type 1 diabetes mellitus. Annu Rev Nutr 26:175-202
2. Mojibian M, Chakir H, Lefebvre DE et al (2009) Diabetes-specific HLA-DR-restricted proinflammatory T cell response to wheat polypeptides in tissue transglutaminase antibody-negative patients with type 1 diabetes. Diabetes 58:1789-1796
3. Knip M, Virtanen SM, Seppa K et al (2010) Dietary intervention in infancy and later signs of beta-cell autoimmunity. N Engl J Med 363:1900-1908
4. Vaarala O, Ilonen J, Ruohtula T et al (2012) Removal of bovine insulin from cow's milk formula and early initiation of beta-cell autoimmunity in the FINDIA Pilot Study. Arch Pediatr Adolesc Med 166:608-614
5. Virtanen SM, Kenward MG, Erkkola M et al (2006) Age at introduction of new foods and advanced beta cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes. Diabetologia 49:1512-1521
6. Sorensen IM, Joner G, Jenum PA, Eskild A, Torjesen PA, Stene LC (2012) Maternal serum levels of 25-hydroxy-vitamin D during pregnancy and risk of type 1 diabetes in the offspring. Diabetes 61:175-178
7. Brown CT, Davis-Richardson AG, Giongo A et al (2011) Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One 6:e25792
8. de Goffau MC, Luopajarvi K, Knip M et al (2012) Fecal microbiota composition differs between children with beta-cell autoimmunity and those without. Diabetes 62:1238-1444
9. Hooper LV, Littman DR, Macpherson AJ (2012) Interactions between the microbiota and the immune system. Science 336:1268-1273
10. Vaarala O, Atkinson MA, Neu J (2008) The «perfect storm» for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 57:2555-2562
11. Secondulfo M, Iafusco D, Carratu R et al (2004) Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type I diabetic patients. Dig Liver Dis 36:35-45
12. Westerholm-Ormio M, Vaarala O, Pihkala P, Ilonen J, Savilahti E (2003) Immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes. Diabetes 52:2287-2295
13. Hadjiyanni I, Li KK, Drucker DJ (2009) Glucagon-like peptide-2 reduces intestinal permeability but does not modify the onset of type 1 diabetes in the nonobese diabetic mouse. Endocrinology 150:592-599
14. Neu J, Reverte CM, Mackey AD et al (2005) Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes. J Pediatr Gastroenterol Nutr 40:589-595
15. Alam C, Valkonen S, Palagani V, Jalava J, Eerola E, Hanninen A (2010) Inflammatory tendencies and overproduction of IL-17 in the colon of young NOD mice are counteracted with diet change. Diabetes 59:2237-2246
16. Atarashi K, Tanoue T, Shima T et al (2011) Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331:337-341
17. Lee YK, Menezes JS, Umesaki Y, Mazmanian SK (2011) Proinflammatory T cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 108(Suppl 1):4615-4622
18. Slack E, Hapfelmeier S, Stecher B et al (2009) Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 325:617-620
19. Brugman S, Klatter FA, Visser JT et al (2006) Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 49:2105-2108
20. Wen L, Ley RE, Volchkov PY et al (2008) Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455:1109-1113
21. Alam C, Valkonen S, Ohls S, Tornqvist K, Hanninen A (2010) Enhanced trafficking to the pancreatic lymph nodes and auto-antigen presentation capacity distinguishes peritoneal B lymphocytes in non-obese diabetic mice. Diabetologia 53:346-355
22. Lee AS, Gibson DL, Zhang Y, Sham HP, Vallance BA, Dutz JP (2010) Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice. Diabetologia 53:741-748
23. Turley SJ, Lee JW, Dutton-Swain N, Mathis D, Benoist C (2005) Endocrine self and gut non-self intersect in the pancreatic lymph nodes. Proc Natl Acad Sci U S A 102:17729-17733
24. Fialkow L, Wang Y, Downey GP (2007) Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic Biol Med 42:153-164
25. Brumell JH, Burkhardt AL, Bolen JB, Grinstein S (1996) Endogenous reactive oxygen intermediates activate tyrosine kinases in human neutrophils. J Biol Chem 271:1455-1461
26. Schreck R, Rieber P, Baeuerle PA (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10:2247-2258
27. Kielland A, Blom T, Nandakumar KS, Holmdahl R, Blomhoff R, Carlsen H (2009) In vivo imaging of reactive oxygen and nitrogen species in inflammation using the luminescent probe L-012. Free Radic Biol Med 47:760-766
28. Zangani M, Carlsen H, Kielland A et al (2009) Tracking early autoimmune disease by bioluminescent imaging of NF-kappaB activation reveals pathology in multiple organ systems. Am J Pathol 174:1358-1367
29. Symonds EL, Riedel CU, O'Mahony D, Lapthorne S, O'Mahony L, Shanahan F (2009) Involvement of T helper type 17 and regulatory T cell activity in Citrobacter rodentium invasion and inflammatory damage. Clin Exp Immunol 157:148-154
30. Kumar A, Wu H, Collier-Hyams LS et al (2007) Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species. EMBO J 26:4457-4466
31. Zangar RC, Bollinger N, Weber TJ, Tan RM, Markillie LM, Karin NJ (2011) Reactive oxygen species alter autocrine and paracrine signaling. Free Radic Biol Med 51:2041-2047
32. Cash HL, Whitham CV, Behrendt CL, Hooper LV (2006) Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313:1126-1130
33. Malinen E, Krogius-Kurikka L, Lyra A et al (2010) Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome. World J Gastroenterol 16:4532-4540
34. Fujimoto T, Imaeda H, Takahashi K et al (2012) Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease. J Gastroenterol Hepatol 28:613-619
35. Kriegel MA, Sefik E, Hill JA, Wu HJ, Benoist C, Mathis D (2011) Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci U S A 108:11548-11553
36. Vaarala O (2011) The gut as a regulator of early inflammation in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 18:241-247
37. Davis CP, Savage DC (1974) Habitat, succession, attachment, and morphology of segmented, filamentous microbes indigenous to the murine gastrointestinal tract. Infect Immun 10:948-956
38. Renz H, Brandtzaeg P, Hornef M (2012) The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat Rev Immunol 12:9-23
39. Visser JT, Bos NA, Harthoorn LF et al (2012) Potential mechanisms explaining why hydrolysed casein based diets outclass single amino acid based diets in the prevention of autoimmune diabetes in diabetes prone BB rats. Diabetes Metab Res Rev 28:505-513
40. Chassin C, Kocur M, Pott J et al (2010) miR-146a mediates protective innate immune tolerance in the neonate intestine. Cell Host Microbe 8:358-368
41. Valladares R, Sankar D, Li N et al (2010) Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS One 5:e10507
42. Ivanov II, Atarashi K, Manel N et al (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485-498
43. Bending D, de la Pena H, Veldhoen M et al (2009) Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest 119:565-572